THE HUPO Human Plasma Proteome Project

Proteomics - Clinical Applications

Volumn 1, Issue 8, 2007, Pages 769-779

  Omenn, Gilbert S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Annotation; Collaborative projects; HUPO; Mass spectrometry; Plasma proteome

Indexed keywords

ALPHA FETOPROTEIN; APC PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; L SELECTIN; LEUKEMIA INHIBITORY FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; POLYCYSTIN 1; PROTEIN P53; PROTEOME; RAG2 PROTEIN; SOMATOMEDIN BINDING PROTEIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANALYTICAL ERROR; BIOINFORMATICS; BREAST CANCER; CARDIOVASCULAR DISEASE; COLON CANCER; COMBINED IMMUNODEFICIENCY; CORRELATION ANALYSIS; DISEASE MARKER; GENETIC ASSOCIATION; HUMAN; IMMUNOASSAY; INFLAMMATION; INFORMATION PROCESSING; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; KIDNEY POLYCYSTIC DISEASE; LIVER DISEASE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OMENN SYNDROME; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STANDARDIZATION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 38349133054     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200700369     Document Type: Review

References (62)

1. Hanash, S. M., Celis, J. E., The Human Proteome Organization: a mission to advance proteome knowledge. Mol. Cell. Proteomics 2002, 1, 413-414.
2. Omenn, G. S., The Human Proteome Organization Plasma Proteome Project pilot phase: reference specimens, technology platform comparisons, and standardized data submissions and analyses. Proteomics 2004, 4, 1235-1240.
3. Omenn, G. S., Ping, P., The future: Translation from discovery to the clinic - roles of HUPO and industry in biomarker discovery. In: Van Eyk, J., Dunn, M. (Eds.), Clinical Proteomics, Wiley-VCH, Weinheim 2007 (in press).
4. Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W. et al., Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of proteins and a publicly-available database. Proteomics 2005, 5, 3226-3245. Proteomics HPPP Special Issue, pp. 3223-3519.
5. Omenn, G. S. (Ed.), Exploring the Human Plasma Proteome. Wiley-VCH, Weinheim 2006.
6. Kersey, P. J., Duarte, J., Williams, A., Karavidopoulou, Y. et al., The International Protein Index: an integrated database for proteomics experiments. Proteomics 2004, 4, 1985-1988 [http://www.ebi.ac.uk/IPI/IPIhelp.htmll.
7. Adamski, M., Blackwell, T., Menon, R., Martens, L. et al., Data management and preliminary data analysis in the pilot phase of the HUPO Plasma Proteome Project. Proteomics 2005, 5, 3246-3261.
8. Kapp, E. A., Schutz, F., Connolly, L. M., Chakel, J. A. et al., An evaluation, comparison and accurate benchmarking of several publicly-available MS/MS search algorithms: sensitivity and specificity analysis. Proteomics 2005, 5, 3475-3490.
9. Carr, S., Aebersold, R., Baldwin, M., The need for guidelines in publication of peptide and protein identification data. Mol. Cell. Proteomics 2004, 3, 351-353.
10. Tang, H. Y., Ali-Khan, N., Echan, L. A., Levenkova, N. et al., A novel 4-dimensional strategy combining protein and peptide separation methods enables detection of low abundance proteins in human plasma and serum proteomes. Proteomics 2005, 5, 3329-3342.
11. Echan, L. A., Tang, H-Y., Ali-Khan, N., Lee, K., Speicher, D. W., Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics 2005, 5, 3292-3303.
12. Omenn, G. S., Menon, R., Adamski, M., Blackwell T. et al., The human plasma and serum proteome. In: Thongboonkerd, V., (Ed.), Proteomics of Human Body Fluids: Principles, Methods, and Applications. Humana Press, Totowa, NJ, USA 2007, pp. 195-224.
13. Beer, I., Barnea, E., Admon, A., Centralized data analysis of a large interlaboratory proteomics project: a feasibility study. Proteomics 2005, 5, 3491-3496.
14. Deutsch, E. W., Eng, J. K., Zhang, H., King, N. L. et al., Human plasma peptide atlas. Proteomics 2005, 5, 3497-3500.
15. Zhang, H., Li, X. J., Martin, D. B., Aebersold, R., Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 2003, 21, 660-666.
16. Yang, Z., Hancock, W. S., Richmond-Chew, T., Bonilla, L., A study of glycoproteins in human serum and plasma reference standards (HUPO) using multi-lectin affinity chromatography coupled with RPLC-MS/MS. Proteomics 2005, 5, 3353-3366.
17. Kuster, B., Schirle, M., Mallick, P., Aebersold, R., Scoring proteomes with proteotypic peptide probes. Nat. Rev. Mol. Cell. Biol. 2005, 6, 577-583.
18. Tanaguchi, N., Miyoshi, E., Jianguo, G., Honke, K., Matsumoto, A., Decoding sugar functions by identifying target glycoproteins. Curr. Opin. Struct. Biol. 2006, 16, 561-566.
19. Wada, Y., Azadi, P., Costello, C.E., Dell, A. et al., Comparison of the methods for profiling glycoprotein glycans: HUPO HGPI (Human Proteome Organization Human Disease Glycomics/Proteome Initiative) multi-institutional study. Glycobiology 2007, 77, 411-422.
20. Rai, A. J., Stemmer, P. M., Zhang, Z., Adam, B. L. et al., Analysis of HUPO PPP reference specimens using SELDITOF mass spectrometry: multi-institution correlation of spectra and identification of biomarkers. Proteomics 2005, 5, 3467-3474.
21. Haab, B. B., Geierstanger, B. H., Michailidis, G., Vitzthum, F. et al., Immunoassay and antibody microarray analysis of the HUPO PPP reference specimens: systematic variation between sample types and calibration of mass spectrometry data. Proteomics 2005, 5, 3278-3291.
22. Ping, P., Vondriska, T. M., Creighton, C.J., Gandhi, T. K. et al., A functional annotation of subproteomes in human plasma. Proteomics 2005, 5, 3506-3519.
23. Berhane, B. T., Zong, C., Liem, D. A., Huang, A. et al., Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics 2005, 5, 3520-3530.
24. Muthasamy, B., Hanumanthu, G., Suresh, S., Rekha, B. et al., Plasma proteome database as a resource for proteornics research. Proteomics 2005, 5, 3531-3536.
25. Fermin, D., Allen, B. B., Blackwell, T. W., Menon, R. et at., Novel gene and gene model detection using a whole genome open reading frame analysis in proteomics. Genome Biol. 2006, 7, R35.
26. States, D. J., Omenn, G. S., Blackwell, T. W., Fermin, D. et al., Deriving high confidence protein identifications from a HUPO collaborative study of human serum and plasma. Nat. Biotechnol. 2006, 24, 333-338.
27. Zheng, J., Gao, X., Beretta, L., He, F. The Human Liver Proteome Project (HLPP) Workshop during the 4th HUPO World Congress. Proteomics 2006, 6, 1716-1718.
28. Hamacher, M., Apweiler R., Arnold, G., Becker, A. et al., HUPO Brain Proteome Project: summary of the pilot phase and introduction of a comprehensive data reprocessing strategy. Proteomics 2006, 6, 4890-4898.
29. Mueller, M., Martens, L., Apweiler, R. Annotating the human proteome: beyond establishing a parts list. Biochim. Biophys. Acta 2007, 1774, 175-191.
30. Haab, B. B., Paulovich, A. G., Anderson, N. L., Clark, A. M. et al., A reagent resource to identify proteins and peptides of interest for the cancer community. Mol. Cell. Proteomics 2006, 5, 1996-2007.
31. Barker, P. E., Wagner, P. D., Stein, S. E., Bunk, D. M. et al,, Standards for plasma and serum proteomics in early cancer detection: a needs assessment from the NIST-NCI SMART workshop. Clin. Chem. 2006, 52, 1669-1674.
32. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
33. Hamacher, M., Marcus, K., Stuhler, K., van Hall, A. et al., (Eds.), Proteomics in Drug Research, Wiley-VCH, Weinheim 2007, p. xiii.
34. Anderson, N. L., Polanski, M, Pieper, R., Gatlin, T. et al., The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics 2004, 3, 311-316.
35. Johnson, R. S., Davis, M. T., Taylor, J. A., Patterson, S. D., Informatics for protein identification by mass spectrometry. Methods 2005, 35, 223-236.
36. Shen, Y., Jacobs, J. M., Camp, D. G. II, Fang, R. et al., Ultrahigh-efficiency strong cation exchange LC/RPLC/MS/MS for high dynamic range characterization of the human plasma proteome. Anal. Chem.. 2004, 76, 1134-1144.
37. Chan, K. C., Lucas, D. A., Hise, D. Schaefer, C. F. et al., Analysis of the human serum proteome. Clin. Proteomics 2004, 1, 101-226.
38. Zhou, M., Lucas, D. A., Chan, K. C., Issaq, H. J. et al., An investigation in the human serum interactome. Eiectrophoresis 2004, 25, 1289-1298
39. Adkins, J. N., Varnum, S. M., Auberry, K. J., Moor, R. J. et al., Toward a human blood serum proteome: analysis by multi-dimensional separation coupled with mass spectrometry. Mol. Cell. Proteomics 2002, 1, 947-952.
40. Rose, K., Bougueleret, L., Baussant, T., Bohm, G. et al., Industrial-scale proteomics: from liters of plasma to chemically synthesized proteins. Proteomics 2004, 4, 2125-2150.
41. Nesvizhskii, A. I., Keller, A., Kolker, E., Aebersold, R., A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75, 4646-4658.
42. Rai, A. J., Gelfand, C. A., Haywood, B. C., Warunek, D. J. et al., Human Proteome Organization-Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 2005, 5, 3262-3277.
43. Misek, D. E., Kuick, R., Wang, H., Galchev, V. et al., A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system. Proteomics 2005, 5, 3343-3352.
44. Tammen, H., Schulte, I., Hess, R., Menzel, C. et al., Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 2005, 5, 3414-3422.
45. Villanueva, J., Shaffer, D.R., Philip, J., Chaparro, C. A. et al., Differential exoprotease activities confer tumor-specific serum peptidome patterns. J. Clin. Invest. 2006, 116, 271-284.
46. Adachi, J., Kumar, C., Zhang, Y., Olsen, J. V., Mann, M., The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006, 7, R80.
47. de Souza, G., Godoy, L. M. F., Mann, M., Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol. 2006, 7, R72.
48. Pilch, B., Mann, M., Large-scale and high-confidence proteomic analysis of human seminal plasma. Genome Biol. 2006, 7, R40.
49. Yoshida, Y., Miyazaki, K., Kamiie, J., Sato, M. et al., Two-dimensional electrophoresis profiling of normal human kidney glomerulus proteome and construction of an extensible markup language (XML)-based database. Proteomics 2005, 5, 1083-1096.
50. Keller, A., Purvine, S., Nesvizhskii, A. I., Stolyar, S. et al., Experimental protein mixture for validating tandem mass spectral analysis. OMICS: A Journal of Integrative Biology 2002, 6, 207-212.
51. Orchard, S., Hermjakob, H., Apweiler, R., The proteomics standards initiative. Proteomics 2003, 3, 1374-1376.
52. Omenn, G. S., Strategies for proteomic profiling of cancers. Proteomics 2006, 6, 5662-5673.
53. Domon, B., Aebersold, R., Mass spectrometry and protein analysis. Science 2006, 312, 212-217.
54. Olsen, J. V., Mann, M., Improved peptide identification in proteomics by two consecutive stages of mass spectrometric fragmentation. Proc. Natl. Acad. Sci. USA 2004, 101, 13417-13422.
55. Aebersold, R., Constellations in a cellular universe. Nature 2003, 422, 115-116.
56. Anderson, L., Hunter, C. L., Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 2006, 5, 573-588.
57. Nesvizhskii, A. I., Roos, F. F., Grossman, J., Vogelzang, M. et al., Dynamic spectrum quality assessment and iterative computational analysis of shotgun proteomic data. Mol. Cell. Proteomics 2006, 5, 652-670.
58. Ransohoff, D. F., Lessons from controversy: ovarian cancer screening and serum proteomics. J. Natl. Cancer Inst. 2005, 97, 315-319.
59. Ransohoff, D. F., Bias as a threat to the validity of cancer molecular-marker research. Nat. Rev. Cancer 2005, 5, 142-149.
60. Bradshaw, R. A., Burlingame, A. L., Carr, S., Aebersold, R., Reporting protein identification data: the next generation of guidelines. Mol. Cell. Proteomics 2006, 5, 787-788.
61. Mischak, H., Apweiler, R., Banks, R. E., Conaway, M. et al., Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin. Appl. 2007, 1, 148-156.
62. Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A. et al, The STARD Statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann. Intern. Med. 2003, 138, W1-W12.